Brief: Atara Biotherapeutics CFO To Step Down
Feb 8 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* ON FEB 3, UTPAL KOPPIKAR, EXECUTIVE VICE PRESIDENT, CFO,
NOTIFIED CO OF HIS INTENTION TO RESIGN, EFFECTIVE MARCH 31, 2023
* ON FEB 3, CO APPOINTED ERIC HYLLENGREN TO SERVE AS SENIOR
VICE
PRESIDENT, CFO, EFFECTIVE AS OF APRIL 1, 2023
Further company coverage: ATRA.O
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM